Immunohistochemical analysis of retinoic acid receptor-alpha in human breast tumors: retinoic acid receptor-alpha expression correlates with proliferative activity.

Retinoids are known to prevent mammary carcinogenesis in rodents and inhibit the growth of human breast cancer cells in vitro. Previously we demonstrated that retinoid inhibition of proliferation of human breast cancer cell lines is largely mediated by retinoic acid receptor (RAR)-alpha. In this study we describe for the first time the histological distribution of RAR-alpha in 33 breast lesion specimens as determined by immunostaining with RAR-alpha antibody. Nuclear staining was observed in tumor tissue and normal portions of the breast samples. Connective tissue exhibited relative uniform staining, whereas a wide range of RAR-alpha expression was found in the epithelial tumor cells. RAR-alpha protein was expressed at significantly higher levels in tumors with greater proliferative activity as determined by immunostaining with Ki-67 antibody. This suggests that RAR-alpha expression may be altered with tumor progression. Although a positive correlation between RAR-alpha mRNA levels and estrogen receptor status of breast tumors has previously been documented, we did not find such a relationship at the protein level. As RAR-alpha plays a major role in retinoid-mediated growth inhibition of human breast cancer cell in vitro, our findings suggest that patients with highly proliferating tumors could be responsive to retinoid independently of their responsiveness to (anti)-estrogens.

[1]  M. Rubin,et al.  9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. , 1994, Cancer research.

[2]  M. Sporn,et al.  Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. , 1994, Cancer research.

[3]  Z. Shao,et al.  Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids. , 1994, The Journal of biological chemistry.

[4]  L. WeiPing,et al.  Epstein‐Barr virus in nasal T‐cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in Western China , 1994, The Journal of pathology.

[5]  M. Sheikh,et al.  Expression of the retinoic Acid nuclear receptors (rars) and retinoid x-receptor (rxr) genes in estrogen-receptor positive and negative breast-cancer. , 1994, International journal of oncology.

[6]  R. Blamey,et al.  Estradiol induction of retinoic acid receptors in human breast cancer cells. , 1993, Cancer research.

[7]  M Buyse,et al.  Adjuvant treatment of stage I lung cancer with high-dose vitamin A. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  P. Chambon,et al.  Multiplicity generates diversity in the retinoic acid signalling pathways. , 1992, Trends in biochemical sciences.

[9]  L. Gudas.  Retinoids, retinoid-responsive genes, cell differentiation, and cancer. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[10]  P. Chambon,et al.  Immunodetection of multiple species of retinoic acid receptor α : evidence for phosphorylation , 1992 .

[11]  C. Clarke,et al.  Expression and regulation of retinoic acid receptors in human breast cancer cells. , 1992, Cancer research.

[12]  R. Evans,et al.  Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. , 1992, Genes & development.

[13]  R. Weber,et al.  13-cis-Retinoic Acid and Interferon α -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin , 1992 .

[14]  P. Chambon,et al.  Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. , 1992, The EMBO journal.

[15]  Gregor Eichele,et al.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor , 1992, Cell.

[16]  J. Grippo,et al.  9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα , 1992, Nature.

[17]  R. Sutherland,et al.  Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[18]  P. Chambon,et al.  Multiple isoforms of the mouse retinoic acid receptor alpha are generated by alternative splicing and differential induction by retinoic acid. , 1991, The EMBO journal.

[19]  P. Chambon,et al.  Differentially expressed isoforms of the mouse retinoic acid receptor beta generated by usage of two promoters and alternative splicing. , 1991, The EMBO journal.

[20]  R Berger,et al.  All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. , 1990, Blood.

[21]  M. Schemper,et al.  Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. , 1990, Cancer research.

[22]  C. McCulloch,et al.  Breast cancer and dietary and plasma concentrations of carotenoids and vitamin A. , 1990, The American journal of clinical nutrition.

[23]  G. Greene,et al.  Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival , 1990, Cancer.

[24]  L J Peters,et al.  Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.

[25]  R. Evans,et al.  Nuclear receptor that identifies a novel retinoic acid response pathway , 1990, Nature.

[26]  J. Fontana,et al.  Retinoic acid inhibition of human breast carcinoma proliferation is accompanied by inhibition of the synthesis of a Mr 39,000 protein. , 1990, Cancer research.

[27]  E. Appella,et al.  H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  G. Kelloff,et al.  Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. , 1989, Cancer research.

[29]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.

[30]  L. Andrac,et al.  Multiparametric evaluation (SAMBA) of growth fraction (monoclonal Ki67) in breast carcinoma tissue sections. , 1988, Cancer research.

[31]  P. Chambon,et al.  Identification of a second human retinoic acid receptor , 1988, Nature.

[32]  Pierre Chambon,et al.  A human retinoic acid receptor which belongs to the family of nuclear receptors , 1987, Nature.

[33]  V. Giguère,et al.  Identification of a receptor for the morphogen retinoic acid , 1987, Nature.

[34]  W. Hong,et al.  13-cis-retinoic acid in the treatment of oral leukoplakia. , 1986, The New England journal of medicine.

[35]  H Stein,et al.  Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. , 1986, Journal of clinical pathology.

[36]  C. Welsch.  Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. , 1985, Cancer research.

[37]  C. Marth,et al.  Effect of retinoic acid and 4-hydroxytamoxifen on human breast cancer cell lines. , 1984, Biochemical pharmacology.

[38]  R. Lotan.  Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. , 1980, Biochimica et biophysica acta.

[39]  H. Bloom,et al.  Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.

[40]  M. Sporn,et al.  The Retinoids : biology, chemistry, and medicine , 1994 .

[41]  V. Sacchini,et al.  Retinoids and tamoxifen in breast cancer chemoprevention , 1993, International journal of clinical & laboratory research.

[42]  P. T. van der Saag,et al.  Retinoic acid receptor and retinoid X receptor expression in retinoic acid—resistant human tumor cell lines , 1993, Molecular carcinogenesis.

[43]  R. Mehta,et al.  Chemoprevention of mammary cancer by retinoids. , 1990, Basic life sciences.

[44]  R. Lotan,et al.  Retinoid-sensitive cells and cell lines. , 1990, Methods in enzymology.

[45]  A. Dejean,et al.  A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma , 1987, Nature.

[46]  M. Sporn,et al.  Cellular biology and biochem-istry of the retinoids , 1984 .

[47]  P. Leroy,et al.  Murine isoforms of retinoic acid receptor y with specific patterns , 2022 .